Multicenter phase II study in advanced pancreatic adenocarcinoma patients treated with a combination of leucovorin, 5FU bolus and infusion, and emcitabine (FOLFUGEM regimen).

被引：0
|
作者：
Hammel, P [1 ]
Louvet, C [1 ]
Andre, T [1 ]
Vanica, R [1 ]
Landi, B [1 ]
Balosso, J [1 ]
Cattan, S [1 ]
Fonck, M [1 ]
Flesch, M [1 ]
Colin, P [1 ]
Gruson, T [1 ]
de Gramont, A [1 ]
机构：
[1] Hosp Beaujon, Clichy, France
来源：
GASTROENTEROLOGY | 1999年 / 116卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
G1828
引用
收藏
页码：A417 / A417
页数：1
相关论文
共 50 条
  • [21] Concomitant administration of weekly oxaliplatin, 5FU continuous infusion and radiotherapy in locally advanced pancreatic cancer (LAPC):: A GERCOR phase II study.
    Moureau-Zabotto, L.
    Phélip, J.
    Afchain, P.
    Mineur, L.
    André, T.
    Vendrely, V.
    Lledo, G.
    Dupuis, O.
    Touboul, E.
    Balosso, J.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 188S - 188S
  • [22] Phase I-II study of gemcitabine (GEM) in combination with 24 hours continuous infusion (CI) of 5-fluorouracil (5-FU) and leucovorin (LV) in patients (pts) with advanced pancreatic carcinoma (APC).
    Lencioni, M
    Falcone, A
    Masi, G
    Fioretto, L
    Di Marsico, R
    Pfanner, E
    Fontana, E
    Galli, C
    Bonifazi, V
    Conte, PF
    ANNALS OF ONCOLOGY, 2000, 11 : 66 - 66
  • [23] A combination of gemcitabine longer infusion and 5fluorouracil bolus in advanced pancreatic cancer. A GISCAD phase II study.
    Cascinu, S
    Frontini, L
    Labianca, R
    Sobrero, A
    Graif, C
    Meregalli, M
    Arnoldi, E
    Pessi, MA
    Cabiddu, M
    Farina, G
    ANNALS OF ONCOLOGY, 2000, 11 : 65 - 65
  • [24] CONTINUOUS 5-FLUOROURACIL (5FU) INFUSION IN CARCINOMA OF THE PANCREAS - A PHASE-II STUDY
    HANSEN, R
    QUEBBEMAN, E
    RITCH, P
    CHITAMBAR, C
    ANDERSON, T
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 1988, 295 (02): : 91 - 93
  • [25] A randomised phase III trial of adjuvant radio-chemotherapy comparing irinotecan, 5FU and Leucovorin to 5FU and Leucovorin in patients with rectal cancer: A Hellenic Cooperative Oncology Group Study
    Kalofonos, H. P.
    Bamias, A.
    Koutras, A.
    Papakostas, P.
    Basdanis, G.
    Samantas, E.
    Karina, M.
    Misailidou, D.
    Pisanidis, N.
    Pentheroudakis, G.
    Economopoulos, T.
    Papadimitriou, C.
    Skarlos, D. V.
    Pectasides, D.
    Stavropoulos, M.
    Bafaloukos, D.
    Kardamakis, D.
    Karanikiotis, C.
    Vourli, G.
    Fountzilas, G.
    EUROPEAN JOURNAL OF CANCER, 2008, 44 (12) : 1693 - 1700
  • [26] Phase II trial of oxaliplatin, 5-FU, and leucovorin chemotherapy for the previously treated patients with advanced gastric cancer
    Oh, S. C.
    Kim, Y.
    Kim, J.
    Choi, I.
    Sung, H.
    Seo, H.
    Shin, S.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [27] 'Tomudex' (raltitrexed) plus 5FU combination treatment for patients with advanced colorectal cancer: a Phase I study
    Mayer, S
    Hilger, R
    Muller, C
    Dohmen, D
    Kloeppel, R
    Vanhoefer, U
    Scheulen, ME
    Seeber, S
    Harstick, A
    EUROPEAN JOURNAL OF CANCER, 1999, 35 : S74 - S74
  • [28] A randomised phase III multicenter trial comparing irinotecan in combination with either the Nordic bolus 5FU and folinic acid (5FU/FA) schedule (FLIRI) or the bolus/infused de Gramont schedule (FOLFIRI), in patients with metastatic colorectal cancer
    Glimelius, B.
    Sorbye, H.
    Balteskard, L.
    Bystrom, P.
    Pfeiffer, P.
    Tveit, K.
    Heikkila, R.
    Keldsen, N.
    Albertsson, M.
    Starkhammar, H.
    Berglund, A.
    EJC SUPPLEMENTS, 2005, 3 (02): : 167 - 167
  • [29] FLUOROURACIL/LEUCOVORIN (5FU/LV) COMBINED WITH IRINOTECAN AND OXALIPLATIN (FOLFIRINOX) AS SECOND LINE CHEMOTHERAPY IN PATIENTS WITH METASTATIC PANCREATIC ADENOCARCINOMA
    Assaf, E.
    Verlinde-Carvalho, M.
    Delbaldo, C.
    Grenier, J.
    Sellam, Z.
    Pouessel, D.
    Sobhani, I.
    Tayyar, C.
    Paul, M.
    Culine, S.
    ANNALS OF ONCOLOGY, 2010, 21 : 233 - 233
  • [30] A Phase II Study of Pelareorep (REOLYSIN®) in Combination with Gemcitabine for Patients with Advanced Pancreatic Adenocarcinoma
    Mahalingam, Devalingam
    Goel, Sanjay
    Aparo, Santiago
    Arora, Sukeshi Patel
    Noronha, Nicole
    Hue Tran
    Chakrabarty, Romit
    Selvaggi, Giovanni
    Gutierrez, Andres
    Coffey, Matthew
    Nawrocki, Steffan T.
    Nuovo, Gerard
    Mita, Monica M.
    CANCERS, 2018, 10 (06)
12345